Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy

NCT01804543 is registered in ClinicalTrials.gov with Westside Medical Associates of Los Angeles as lead sponsor.

NCT NCT01804543
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01804543 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Ranolazine on Myocardial Ischemia Detected by High-Field 3T Cardiovascular Magnetic Resonance (CMR) Imaging and P-31 Spectroscopy
Lead sponsor
Westside Medical Associates of Los Angeles
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2012
Completion date
December 31, 2014
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

angina, heart disease